# Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)

> **NCT00163462** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 750 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Ciclesonide

## Key facts

- **NCT ID:** NCT00163462
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 750 (—)
- **Last updated:** 2016-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00163462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00163462, "Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00163462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*